Symbol="OMER"
AssetType="Common Stock"
Name="Omeros Corporation"
Description="Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and markets protein and small molecule therapies, and orphan indications targeting inflammation, complement-mediated diseases, central nervous system (CNS) disorders, and system-related diseases. immunological. The company is headquartered in Seattle, Washington."
CIK="1285819"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="201 ELLIOTT AVENUE WEST, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="226909000"
EBITDA="-166516000"
PERatio="None"
PEGRatio="-0.17"
BookValue="0.326"
DividendPerShare="0"
DividendYield="0"
EPS="-3.18"
RevenuePerShareTTM="-0.479"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.24"
ReturnOnEquityTTM="-7.29"
RevenueTTM="-30004000"
GrossProfitTTM="-71397000"
DilutedEPSTTM="-3.18"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.149"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.934"
PriceToBookRatio="8.44"
EVToRevenue="8.26"
EVToEBITDA="-1.514"
Beta="0.957"
num_52WeekHigh="7.8"
num_52WeekLow="1.735"
num_50DayMovingAverage="4.714"
num_200DayMovingAverage="4.233"
SharesOutstanding="62856000"
DividendDate="None"
ExDividendDate="None"
symbol="OMER"
open="3.82"
high="3.86"
low="3.54"
price="3.61"
volume="315521.00"
latest_trading_day="2023-08-28"
previous_close="3.81"
change="-0.20"
change_percent="-5.2493%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="24"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="76"
Volume_recent_avg="604937"
Change_recent_avg="0.01"
Delta_recent_avg="0.42"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="76"
Aroon_momentum_negative="24"
image_negative_thumbnail_id_1="151"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0025.jpeg"
image_negative_thumbnail_id_2="1163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="962"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
